Satellite Symposia

Wednesday July 8, 2015

Symposium presented by ASTRAZENECA

13:45-14:45

Finding the Key to Individualizing Treatment in Type 2 Diabetes
Chairperson: André Carpentier
Objectives
  • Identify appropriate therapeutic targets for T2DM patients with different characteristics
  • Ask the relevant questions to guide the individualization of treatment options and take into consideration patient and medication factors
  • Discuss the advantages and disadvantages of the range of antihyperglycemic agents when used as add-on to insulin
  • Distinguish the role of newer pharmacological agents such as GLP-1 agonists, DPP-4 inhibitors and SGLT2 inhibitors as add-on to insulin
13:45-13:55 Introduction André Carpentier
13:55-14:35 Presentation of SGLT2 inhibitors and discussion of different therapeutic choices for a patient on insulin Ronald Goldenberg
14:35-14:45 Questions and discussion  

Wednesday July 8, 2015

Symposium presented by AMGEN CANADA

15:30-17:00

The Challenges of Dyslipidemia Management in Cardiometabolic Disease
Chairperson: Lawrence Leiter
Objectives
  • Review of the current dyslipidemia landscape and evolving research impacting clinical management of cardiometabolic disease
  • Update on the dyslipidemia of diabetes and review of challenges in its management
  • Explain emerging therapies that may impact on the management of dyslipidemia, including the discovery of the role of PCSK9 in LDL-cholesterol metabolism and targeted therapies to block PCSK9 in order to reduce cardiovascular risk
  • Discuss how cardiometabolic disease research in familial hypercholesterolemia is leading to new therapeutic discoveries and treatment options for patients
15:30-15:50
Challenge of dyslipidemia in patients with diabetes
Lawrence Leiter
15:50-16:20
Pathways to emerging therapies
Philip Barter
16:20-16:40
Familial hypercholesterolemia and new therapeutic discoveries
Daniel Gaudet
16:40-17:00
Panel discussion
Faculty

Wednesday July 8, 2015

Symposium presented by INTERNATIONAL MEDICAL PRESS AND INSTITUTE FOR MEDICAL AND NURSING EDUCATION

17:15-18:45

Pharmacotherapy and Weight Control: Why, What and When?
Chairperson: Jean-Pierre Després
Objectives
  • Consider presence of other conditions when implementing weight management strategies
  • Implement strategies to counter weight regain and promote long-term weight control
17:15-17:20 Introduction Jean-Pierre Després
17:20-17:40 Impact of weight loss on cardiometabolic risk  Paul Poirier
17:40-18:00 Tailored approaches to weight control. Is all weight loss the same? Luc Van Gaal
18:00-18:20 Pharmacotherapy, weight loss and fat depots Lawrence Leiter
18:20-18:45 Integrating weight control into the overall management of cardiometabolic risk Interactive discussion

This CME-accredited symposium is supported by an educational grant from Novo Nordisk A/S

Friday July 10, 2015

Symposium presented by YINI and DANONE INSTITUTE OF CANADA

15:30-16:40

Yogurt and Type 2 Diabetes: Overview of the Evidence
Chairpersons: Angelo Tremblay/André Marette
15:30-15:35 Introduction Angelo Tremblay
15:35-16:15 Yogurt and diabetes: evidence from worldwide cohorts Frank Hu
16:15-16:30 Discussion on mechanisms of action André Marette
16:30-16:40 Question and answer period  

Visit our social networks

Important Dates

Abstract submission opening
January 7, 2015
Abstract submission deadline
March 29, 2015  May 31, 2015
Notification of acceptance
April 21, 2015
Registration opening
January 7, 2015
Registration for presenting authors
May 31, 2015
Early bird registration
May 31, 2015

Newsletter